ScholarLens Back to search
1964•Experimental Biology and MedicineRequires access

Hypocholesterolemic Effect of an Androsterone Analogue

Robert E. Ranney, Francis J. Saunders

Open publisher page 4 citations

Abstract

An assay was devised in which the hypocholesterolemic action of parenterally administered androsterone could be demonstrated in rats given a low dose of propyl-thiouracil. Using this procedure an analogue of androsterone, 3α-methoxy-17α-methyl-5α-androstan-17-ol (SC-12790), was found to have an oral hypocholesterolemic activity similar to that of parenterally administered androsterone. Endocrine assays indicated the new steroid to be a weak androgen of the same order of potency as androsterone.

About this research paper

What this paper is about

An assay was devised in which the hypocholesterolemic action of parenterally administered androsterone could be demonstrated in rats given a low dose of propyl-thiouracil. Using this procedure an analogue of androsterone, 3α-methoxy-17α-methyl-5α-androstan-17-ol (SC-12790), was found to have an oral hypocholesterolemic activity similar to that of parenterally administered androsterone. Endocrine assays indicated the new steroid to be a weak androgen of the same order of potency as androsterone.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

An assay was devised in which the hypocholesterolemic action of parenterally administered androsterone could be demonstrated in rats given a low dose of propyl-thiouracil. Using this procedure an analogue of androsterone, 3α-methoxy-17α-methyl-5α-androstan-17-ol (SC-12790), was found to have an oral hypocholesterolemic activity similar to that of parenterally administered androsterone. Endocrine assays indicated the new steroid to be a weak androgen of the same order of potency as androsterone.

Key concepts: Androsterone, Etiocholanolone, Endocrinology, Chemistry, Potency, Internal medicine, Endocrine system, Pharmacology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Hypocholesterolemic Effect of an Androsterone Analogue — Research Paper | ScholarLens